These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 23465675)
1. Use of high-resolution computed tomography and positron emission tomography/computed tomography in the management of stage IA adenocarcinoma. Miyata Y; Tsutani Y; Okada M Semin Thorac Cardiovasc Surg; 2012; 24(4):267-74. PubMed ID: 23465675 [TBL] [Abstract][Full Text] [Related]
2. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678 [TBL] [Abstract][Full Text] [Related]
4. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546 [TBL] [Abstract][Full Text] [Related]
5. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694 [TBL] [Abstract][Full Text] [Related]
6. Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography. Shiono S; Yanagawa N; Abiko M; Sato T Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):637-43. PubMed ID: 24994703 [TBL] [Abstract][Full Text] [Related]
7. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M Ann Thorac Surg; 2014 May; 97(5):1701-7. PubMed ID: 24679941 [TBL] [Abstract][Full Text] [Related]
8. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary? Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165 [TBL] [Abstract][Full Text] [Related]
9. Performance of fluorodeoxyglucose-positron-emission tomography/computed tomography for evaluating tumor response to nonsurgical treatment. Ishihara K; Kobayashi Y; Iwano M; Shiiba M; Yoshihara H; Satoh H; Akiyama K; Kumita S J Nippon Med Sch; 2011; 78(5):272-3. PubMed ID: 22041872 [No Abstract] [Full Text] [Related]
10. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488 [TBL] [Abstract][Full Text] [Related]
11. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938 [TBL] [Abstract][Full Text] [Related]
12. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes. Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324 [TBL] [Abstract][Full Text] [Related]
13. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer. Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911 [TBL] [Abstract][Full Text] [Related]
14. What are the radiologic findings predictive of indolent lung adenocarcinoma? Mimae T; Miyata Y; Tsutani Y; Mimura T; Nakayama H; Okumura S; Yoshimura M; Okada M Jpn J Clin Oncol; 2015 Apr; 45(4):367-72. PubMed ID: 25628349 [TBL] [Abstract][Full Text] [Related]
15. Recent progress in positron emission tomography concerning diagnosis and treatment of lung cancer. Nakamura H Ann Thorac Cardiovasc Surg; 2012; 18(2):85-8. PubMed ID: 22523107 [No Abstract] [Full Text] [Related]
16. Tumour metabolic activity measured by fluorodeoxyglucose positron emission tomography for radiotherapy planning as a prognostic factor for locally advanced non-small cell lung cancer. Masarykova A; Scepanovic D; Povinec P; Bires P; Lederleitner D; Pobijakova M Bratisl Lek Listy; 2018; 119(3):133-138. PubMed ID: 29536740 [TBL] [Abstract][Full Text] [Related]
17. A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT. Erhamamci S; Reyhan M; Canpolat T; Nursal GN; Yapar AF Clin Nucl Med; 2016 Mar; 41(3):e146-8. PubMed ID: 26562574 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value. Shiono S; Abiko M; Okazaki T; Chiba M; Yabuki H; Sato T Eur J Cardiothorac Surg; 2011 Nov; 40(5):1165-9. PubMed ID: 21507671 [TBL] [Abstract][Full Text] [Related]
19. Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index. Shiono S; Yanagawa N; Abiko M; Sato T Ann Thorac Cardiovasc Surg; 2015; 21(3):236-41. PubMed ID: 25740450 [TBL] [Abstract][Full Text] [Related]
20. [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Watanabe K; Nomori H; Ohtsuka T; Naruke T; Ebihara A; Orikasa H; Yamazaki K; Uno K; Kobayashi T; Goya T Jpn J Clin Oncol; 2006 Jul; 36(7):403-9. PubMed ID: 16782729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]